14158 Results (Page 541 of 567)
All Market Research Reports
South Africa Dental Implant Market Analysis
South Africa Dental Implant Market was valued at $32.40 Mn in 2023 and is predicted to grow at a CAGR of 11.03% from 2023 to 2030, to $67.50 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
UK Head and Neck Cancer Therapeutics Market Analysis
The UK Head and Neck Cancer Therapeutics Market was valued at $1.96 Mn in 2023 and is predicted to grow at a CAGR of 12.70% from 2023 to 2030, to $4.53 Mn by 2030. The key drivers of this industry include growing cancer incidence, government initiatives, and technological innovations. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
Singapore Conjunctivitis Therapeutics Market Analysis
The Singapore Conjunctivitis Therapeutics Market was valued at $5 Mn in 2022 and is predicted to grow at a CAGR of 6% from 2023 to 2030, to $8 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, new therapeutics development in the industry, and supportive government initiatives. The industry is primarily dominated by players such as Allergan, Bausch & Lomb, Novartis, Rohto, Santen, Sirion, and Alembic among others.
Spain PET Scan Market Analysis
The Spain PET Scan Market was valued at $37.4 Mn in 2023 and is predicted to grow at a CAGR of 4.4% from 2023 to 2030, to $50.6 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the Spain PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
India Dental Implant Market Analysis
India Dental Implant Market was valued at $90.80 Mn in 2023 and is predicted to grow at a CAGR of 12.8% from 2023 to 2030, to $210.90 Mn by 2030. The key drivers of this industry are a growing geriatric population, improved dental infrastructure, and increasing demand for cosmetic dentistry. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
China Head and Neck Cancer Therapeutics Market Analysis
The China Head and Neck Cancer Therapeutics Market was valued at $31.72 Mn in 2023 and is predicted to grow at a CAGR of 10.50% from 2023 to 2030, to $63.81 Mn by 2030. The key drivers of this industry include an aging population, advancement in treatment, and growth in the healthcare sector. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
South Africa Conjunctivitis Therapeutics Market Analysis
The South Africa Conjunctivitis Therapeutics Market was valued at $27 Mn in 2022 and is predicted to grow at a CAGR of 6.63% from 2023 to 2030, to $45 Mn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, expanding healthcare access, and innovation in therapeutics. The industry is primarily dominated by players such as Allergan, Novartis, Sirion, Boehringer Ingelheim, Pfizer, and others.
UK PET Scan Market Analysis
The UK PET Scan Market was valued at $50.4 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $63.7 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the UK PET Scan Market are Siemens Healthineers, Toshiba, GE Healthcare, Hitachi, Canon Medical Systems, among others.
Canada Genomic Diagnostics Market Analysis
Canada Genomic Diagnostics Market was valued at $2,612 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $7,607.72 Mn by 2030. The key drivers of this industry include early disease detection, personalized medicine, and government funding. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Indonesia Head and Neck Cancer Therapeutics Market Analysis
The Indonesia Head and Neck Cancer Therapeutics Market was valued at $44.65 Mn in 2023 and is predicted to grow at a CAGR of 10.70% from 2023 to 2030, to $90.96 Mn by 2030. The key drivers of this industry include the growing aging population, advancement in treatment, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Roche, and Pfizer among others.
China PET Scan Market Analysis
The China PET Scan Market was valued at $155.9 Mn in 2023 and is predicted to grow at a CAGR of 6.9% from 2023 to 2030, to $248.8 Mn by 2030. The key drivers of the market include the rising prevalence of chronic diseases, rising demand for non-invasive diagnostic devices, and increased demand for early diagnosis. The prominent players of the China PET Scan Market are GE Healthcare, Siemens Healthineers, Basda Medical, Toshiba, Schiller, and Hitachi, among others.
US Genomic Diagnostics Market Analysis
US Genomic Diagnostics Market was valued at $13,713 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $35,381.06 Mn by 2030. The key drivers of this industry include strong demand for early & preventive care, precision medicine & personalized treatments, and government funding & initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Japan Head and Neck Cancer Therapeutics Market Analysis
The Japan Head and Neck Cancer Therapeutics Market was valued at $33.55 Mn in 2023 and is predicted to grow at a CAGR of 11.50% from 2023 to 2030, to $71.88 Mn by 2030. The key drivers of this industry include the aging population, advanced healthcare system, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer and AstraZeneca among others.
UAE Conjunctivitis Therapeutics Market Analysis
The UAE Conjunctivitis Therapeutics Market was valued at $21 Mn in 2022 and is predicted to grow at a CAGR of 6.4% from 2023 to 2030, to $34 Mn by 2030. The key drivers of this industry include a surge in the prevalence of conjunctivitis, increasing government investments, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Julphar, Santen, and Neopharma among others.
Indonesia PET Scan Market Analysis
The Indonesia PET Scan Market was valued at $11.6 Mn in 2023 and is predicted to grow at a CAGR of 5.4% from 2023 to 2030, to $16.8 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Indonesia PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Saudi Arabia Genomic Diagnostics Market Analysis
Saudi Arabia Genomic Diagnostics Market was valued at $555.05 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.10 Mn by 2030. The key drivers of this industry include increasing prevalence, government initiatives, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Malaysia Head and Neck Cancer Therapeutics Market Analysis
The Malaysia Head and Neck Cancer Therapeutics Market was valued at $23.55 Mn in 2023 and is predicted to grow at a CAGR of 11.50% from 2023 to 2030, to $50.45 Mn by 2030. The key drivers of this industry include increasing cancer incidence, advanced treatment options, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer, and AstraZeneca among others.
Japan PET Scan Market Analysis
The Japan PET Scan Market was valued at $120.6 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $180.1 Mn by 2030. The key drivers of the market include expanding applications in medical field, rising advantages over other imaging techniques, and technological advancements. The prominent players of the Japan PET Scan Market are GE Healthcare, Siemens Healthineers, Terumo, Toshiba, Schiller, and Hitachi, among others.
UAE Genomic Diagnostics Market Analysis
UAE Genomic Diagnostics Market was valued at $163.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $504.80 Mn by 2030. The key drivers of this industry include rising prevalence of genetic conditions, growing awareness, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Singapore Head and Neck Cancer Therapeutics Market Analysis
The Singapore Head and Neck Cancer Therapeutics Market was valued at $20.74 Mn in 2023 and is predicted to grow at a CAGR of 14% from 2023 to 2030, to $51.90 Mn by 2030. The key drivers of this industry include advancement in treatment, healthcare expenditure, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer, and AstraZeneca among others.
US Conjunctivitis Therapeutics Market Analysis
The US Conjunctivitis Therapeutics Market was valued at $1.722 Bn in 2022 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $2.250 Bn by 2030. The key drivers of this industry include the rising prevalence of conjunctivitis, increasing healthcare expenditure, and technological advancements in the therapeutics industry. The industry is primarily dominated by players such as Allergan, Pfizer, Novartis, Santen, IBA Vision, Alembic, and Bausch & Lomb among others.
Malaysia PET Scan Market Analysis
The Malaysia PET Scan Market was valued at $3.1 Mn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $4.6 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Malaysia PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
Brazil Genomic Diagnostics Market Analysis
Brazil Genomic Diagnostics Market was valued at $816.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $2,523.99 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, technological advancements, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Philippines Head and Neck Cancer Therapeutics Market Analysis
The Philippines Head and Neck Cancer Therapeutics Market was valued at $6.10 Mn in 2023 and is predicted to grow at a CAGR of 13.50% from 2023 to 2030, to $14.80 Mn by 2030. The key drivers of this industry include public-private partnerships, healthcare expenditure, and government initiatives. The industry is primarily dominated by players such as Bristol Myers Squibb, Merck, Pfizer, and AstraZeneca among others.
Philippines PET Scan Market Analysis
The Philippines PET Scan Market was valued at $4.3 Mn in 2023 and is predicted to grow at a CAGR of 5.9% from 2023 to 2030, to $6.4 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Philippines PET Scan Market are GE Healthcare, Siemens Healthineers, Toshiba, Schiller, and Hitachi, among others.
